To confirm the functional role of increased IL-1β signaling in human AML pathogenesis, immunodeficient NSG-SGM3 mice were transplanted with CD34+ progenitors isolated from the BM of AML patients, and treated in vivo with either human IL-1β or vehicle. The gene discussed is IL1B; the disease is acute myeloid leukemia.